KR970701714A - 에폭사이드의 제조방법(Process for making epoxide) - Google Patents

에폭사이드의 제조방법(Process for making epoxide)

Info

Publication number
KR970701714A
KR970701714A KR1019960704836A KR19960704836A KR970701714A KR 970701714 A KR970701714 A KR 970701714A KR 1019960704836 A KR1019960704836 A KR 1019960704836A KR 19960704836 A KR19960704836 A KR 19960704836A KR 970701714 A KR970701714 A KR 970701714A
Authority
KR
South Korea
Prior art keywords
epoxide
making epoxide
making
renin
proteases
Prior art date
Application number
KR1019960704836A
Other languages
English (en)
Other versions
KR100387741B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22764868&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR970701714(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of KR970701714A publication Critical patent/KR970701714A/ko
Application granted granted Critical
Publication of KR100387741B1 publication Critical patent/KR100387741B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019960704836A 1994-03-04 1995-02-27 에폭사이드의제조방법 KR100387741B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20607494A 1994-03-04 1994-03-04
US08/206,074 1994-03-04

Publications (2)

Publication Number Publication Date
KR970701714A true KR970701714A (ko) 1997-04-12
KR100387741B1 KR100387741B1 (ko) 2003-10-04

Family

ID=22764868

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960704836A KR100387741B1 (ko) 1994-03-04 1995-02-27 에폭사이드의제조방법

Country Status (25)

Country Link
EP (1) EP0748319B1 (ko)
JP (1) JP3871705B2 (ko)
KR (1) KR100387741B1 (ko)
CN (1) CN1066728C (ko)
AT (1) ATE210662T1 (ko)
AU (1) AU690231B2 (ko)
BR (1) BR9506977A (ko)
CA (1) CA2183976C (ko)
CZ (1) CZ291816B6 (ko)
DE (1) DE69524578T2 (ko)
DK (1) DK0748319T3 (ko)
ES (1) ES2167419T3 (ko)
FI (1) FI120259B (ko)
HR (1) HRP950096B1 (ko)
HU (1) HU222750B1 (ko)
MX (1) MX9603871A (ko)
NZ (1) NZ281866A (ko)
PT (1) PT748319E (ko)
RO (1) RO117696B1 (ko)
RU (1) RU2137769C1 (ko)
SK (1) SK283067B6 (ko)
TW (1) TW380137B (ko)
UA (1) UA45968C2 (ko)
WO (1) WO1995023797A1 (ko)
YU (1) YU49010B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728840A (en) * 1994-03-04 1998-03-17 Merck & Co., Inc. Process for making an epoxide
TW415948B (en) * 1995-10-30 2000-12-21 Merck & Co Inc Process for synthesizing epoxide and halohydrin
US5981759A (en) * 1997-06-20 1999-11-09 Merck & Co., Inc. Process for indinavir intermediate
PL2623113T3 (pl) 2005-11-09 2018-05-30 Onyx Therapeutics, Inc. Związek do hamowania enzymu
DK2041158T3 (da) 2006-06-19 2013-06-24 Onyx Therapeutics Inc Peptid-epoxidketoner til proteasom inhibering
KR20170125413A (ko) * 2007-10-04 2017-11-14 오닉스 세라퓨틱스, 인크. 결정형 펩티드 에폭시 케톤 프로테아제 저해제 및 아미노산 케토-에폭시드의 합성
WO2010048298A1 (en) 2008-10-21 2010-04-29 Proteolix, Inc. Combination therapy with peptide epoxyketones
AR075899A1 (es) 2009-03-20 2011-05-04 Onyx Therapeutics Inc Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
US8853147B2 (en) 2009-11-13 2014-10-07 Onyx Therapeutics, Inc. Use of peptide epoxyketones for metastasis suppression
US9359398B2 (en) 2010-03-01 2016-06-07 Onyx Therapeutics, Inc. Compounds for immunoproteasome inhibition
EP2563781B1 (en) * 2010-04-30 2016-10-26 Indiana University Research and Technology Corporation Processes for preparing linezolid
WO2014011695A2 (en) 2012-07-09 2014-01-16 Onyx Therapeutics, Inc. Prodrugs of peptide epoxy ketone protease inhibitors
CN104692987B (zh) * 2015-01-22 2017-05-17 北京大学 卤代醇及其衍生物的廉价高效合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072237A1 (en) * 1991-07-02 1993-01-03 Merck & Co., Inc. Stereoselective production of hydroxyamide compounds from chiral –-amino epoxides
CA2081970C (en) * 1991-11-08 1997-07-08 Joseph P. Vacca Hiv protease inhibitors useful for the treatment of aids

Also Published As

Publication number Publication date
SK283067B6 (sk) 2003-02-04
EP0748319A1 (en) 1996-12-18
HUT75611A (en) 1997-05-28
DE69524578T2 (de) 2002-07-18
ATE210662T1 (de) 2001-12-15
DK0748319T3 (da) 2002-03-18
JPH09509929A (ja) 1997-10-07
RU2137769C1 (ru) 1999-09-20
FI963452A (fi) 1996-09-03
EP0748319B1 (en) 2001-12-12
ES2167419T3 (es) 2002-05-16
BR9506977A (pt) 1997-09-02
TW380137B (en) 2000-01-21
FI963452A0 (fi) 1996-09-03
UA45968C2 (uk) 2002-05-15
YU14595A (sh) 1997-12-05
CN1146768A (zh) 1997-04-02
HU222750B1 (hu) 2003-09-29
NZ281866A (en) 1998-05-27
AU1882895A (en) 1995-09-18
CZ254396A3 (en) 1997-01-15
RO117696B1 (ro) 2002-06-28
CA2183976C (en) 2005-02-01
HRP950096B1 (en) 2002-06-30
CZ291816B6 (cs) 2003-06-18
JP3871705B2 (ja) 2007-01-24
WO1995023797A1 (en) 1995-09-08
PT748319E (pt) 2002-05-31
HRP950096A2 (en) 1997-06-30
AU690231B2 (en) 1998-04-23
MX9603871A (es) 1997-07-31
CA2183976A1 (en) 1995-09-08
DE69524578D1 (de) 2002-01-24
KR100387741B1 (ko) 2003-10-04
SK112296A3 (en) 1997-02-05
FI120259B (fi) 2009-08-31
CN1066728C (zh) 2001-06-06
HU9602412D0 (en) 1996-11-28
YU49010B (sh) 2003-04-30

Similar Documents

Publication Publication Date Title
DK0443449T3 (da) Fremgangsmåde til fremstilling af oxetanoner
KR970701714A (ko) 에폭사이드의 제조방법(Process for making epoxide)
MXPA04002067A (es) Nuevas dihidropteridinonas, procedimientos para su preparacion y su uso como medicamento.
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
WO2002055383A3 (en) Monolithic part and process for making the same
WO2001057014A3 (en) Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
ATE239716T1 (de) Synthese von 3,6-dialkyl-5,6-dihydro-4-hydroxy-2h-pyran-2-on
AR000813A1 (es) Procedimiento para la obtencion de n-aril y n-heteroarilhidroxilaminas
YU45896A (sh) Postupak za dobijanje epoksida
YU55900A (sh) Postupak za sintezu inhibitora hiv proteaze
DE69432176D1 (de) Verfahren zur herstellung von hiv protease inhibitoren
HUP9903318A2 (hu) Intermedierek taxol előállítására
HUP9904510A2 (hu) Benzotiofének előállítására szolgáló eljárás
EA199900772A1 (ru) Способ селективного эпоксидирования для получения лекарственных соединений
ATE223414T1 (de) Prozess zur herstellung von zwischebprodukten für imidazodeazepinen
SE0001866D0 (sv) A new process
GB2369356B (en) Process
ATE247646T1 (de) Herstellung von 2-ethyl-3-methyl-1,4-diazin
MXPA04004537A (es) Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos.
TW200611691A (en) Retroviral protease inhibiting compounds

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110530

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee